TY - JOUR
T1 - Hypoxia-inducible factor-1α correlates with MET and metastasis in node-negative breast cancer
AU - Chen, Helen H.W.
AU - Su, Wu Chou
AU - Lin, Pin Wen
AU - Guo, How Ran
AU - Lee, Wen Ying
N1 - Funding Information:
Acknowledgements This work was supported by grants from National Science Council (NSC 93-2320-B-384-003), National Cheng Kung University Hospital (NCKUH-94-013), and Chi Mei Medical Center (CMNSC-9304), Taiwan.
PY - 2007/6
Y1 - 2007/6
N2 - The mechanism of tumor hypoxia promoting metastasis remains uncertain. Hypoxia-inducible factor-1α (HIF-1α) is a key mediator of the cellular response to hypoxia and binds the met promoter, resulting in increased expression of MET. In breast cancer, MET overexpression is associated with death caused by metastatic disease. Aim of this study is to investigate the role of HIF-1α in MET expression and metastasis in lymph node negative breast cancer. We recruited a homogeneous cohort of 104 patients with T 1-2N0M0 breast carcinoma, who had undergone primary surgery. Fifty-three patients had distant metastases and 51 patients had no evidence of disease for more than 10 years. We analyzed the expressions of HIF-1α and MET in these patients using immunohistochemistry. HIF-1α and MET were positively correlated (Spearman's rank correlation coefficient, 0.35; P < 0.01), were independent predictors of distant metastasis (P = 0.002 and P = 0.03, respectively), and correlated with poor 10-year disease-free survival rate (P < 0.001 for both). Furthermore, co-overexpression of HIF-1α and MET was a significant independent predictor of distant metastasis (odd radio, 10.78; P < 0.001), and patients with co-overexpression had a significantly worse 10-year disease-free survival rate. The results provide evidence that tumor hypoxia promotes metastasis through the induction of MET overexpression by HIF-1α and emphasize the promising status of HIF-1α as a therapeutic target against metastasis in node-negative breast cancer.
AB - The mechanism of tumor hypoxia promoting metastasis remains uncertain. Hypoxia-inducible factor-1α (HIF-1α) is a key mediator of the cellular response to hypoxia and binds the met promoter, resulting in increased expression of MET. In breast cancer, MET overexpression is associated with death caused by metastatic disease. Aim of this study is to investigate the role of HIF-1α in MET expression and metastasis in lymph node negative breast cancer. We recruited a homogeneous cohort of 104 patients with T 1-2N0M0 breast carcinoma, who had undergone primary surgery. Fifty-three patients had distant metastases and 51 patients had no evidence of disease for more than 10 years. We analyzed the expressions of HIF-1α and MET in these patients using immunohistochemistry. HIF-1α and MET were positively correlated (Spearman's rank correlation coefficient, 0.35; P < 0.01), were independent predictors of distant metastasis (P = 0.002 and P = 0.03, respectively), and correlated with poor 10-year disease-free survival rate (P < 0.001 for both). Furthermore, co-overexpression of HIF-1α and MET was a significant independent predictor of distant metastasis (odd radio, 10.78; P < 0.001), and patients with co-overexpression had a significantly worse 10-year disease-free survival rate. The results provide evidence that tumor hypoxia promotes metastasis through the induction of MET overexpression by HIF-1α and emphasize the promising status of HIF-1α as a therapeutic target against metastasis in node-negative breast cancer.
UR - http://www.scopus.com/inward/record.url?scp=34249006269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34249006269&partnerID=8YFLogxK
U2 - 10.1007/s10549-006-9360-3
DO - 10.1007/s10549-006-9360-3
M3 - Article
C2 - 17028975
AN - SCOPUS:34249006269
SN - 0167-6806
VL - 103
SP - 167
EP - 175
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 2
ER -